IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 319 filers reported holding IMMUNOMEDICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,897,000 | -7.1% | 53,540 | -45.4% | 0.42% | +37.8% |
| Q3 2018 | $2,042,000 | -41.5% | 98,026 | -33.5% | 0.30% | -44.7% |
| Q2 2018 | $3,489,000 | +374.7% | 147,400 | +193.2% | 0.55% | +350.8% |
| Q1 2018 | $735,000 | -25.9% | 50,280 | -18.1% | 0.12% | -31.5% |
| Q4 2017 | $992,000 | -81.7% | 61,412 | -84.2% | 0.18% | -75.3% |
| Q3 2017 | $5,419,000 | +21.0% | 387,616 | -23.6% | 0.72% | -2.7% |
| Q2 2017 | $4,478,000 | +404.8% | 507,114 | +270.1% | 0.74% | +428.6% |
| Q1 2017 | $887,000 | -24.0% | 137,028 | -27.3% | 0.14% | -39.9% |
| Q3 2013 | $1,167,000 | +13.5% | 188,594 | -0.2% | 0.23% | +4.5% |
| Q2 2013 | $1,028,000 | – | 188,919 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
| First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
| Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
| DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
| Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
| Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
| Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
| Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
| Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |